Search research articles
Contact Us
Filters
Showing results (211-220 of 224) with videos related to
Page
of 23
Sort By:
American Journal of Hematology
|
January 6, 2026
Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy
Stefan Markus Dendorfer, Katharina Schmidt-Brücken, Michael Kramer, et al.
The Lancet. Oncology
|
November 10, 2015
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
Christoph Röllig, Hubert Serve, Andreas Hüttmann, et al.
Blood Advances
|
November 18, 2021
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
Jan M Middeke, Klaus H Metzeler, Christoph Röllig, et al.
JCI Insight
|
February 8, 2023
Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness
Allan Feng, Emily Y Yang, Andrew Reese Moore, et al.
Blood Advances
|
November 6, 2024
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia
Leo Ruhnke, Marius Bill, Sven Zukunft, et al.
Nature Communications
|
September 15, 2021
New-onset IgG autoantibodies in hospitalized patients with COVID-19
Sarah Esther Chang, Allan Feng, Wenzhao Meng, et al.
Haematologica
|
June 9, 2022
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4
Sabine Kayser, David Martínez-Cuadrón, Maher Hanoun, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 3, 2021
New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19
Sarah Esther Chang, Allan Feng, Wenzhao Meng, et al.
Leukemia
|
January 12, 2026
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)
Andreas Burchert, Franck E Nicolini, Philipp le Coutre, et al.
BMC Cancer
|
December 7, 2016
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011
Olaf Schoffer, Stefanie Schülein, Gerlinde Arand, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 224) with videos related to
Sort By:
Page
of 23
American Journal of Hematology
|
January 6, 2026
Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy
Stefan Markus Dendorfer, Katharina Schmidt-Brücken, Michael Kramer, et al.
The Lancet. Oncology
|
November 10, 2015
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
Christoph Röllig, Hubert Serve, Andreas Hüttmann, et al.
Blood Advances
|
November 18, 2021
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
Jan M Middeke, Klaus H Metzeler, Christoph Röllig, et al.
JCI Insight
|
February 8, 2023
Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness
Allan Feng, Emily Y Yang, Andrew Reese Moore, et al.
Blood Advances
|
November 6, 2024
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia
Leo Ruhnke, Marius Bill, Sven Zukunft, et al.
Nature Communications
|
September 15, 2021
New-onset IgG autoantibodies in hospitalized patients with COVID-19
Sarah Esther Chang, Allan Feng, Wenzhao Meng, et al.
Haematologica
|
June 9, 2022
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4
Sabine Kayser, David Martínez-Cuadrón, Maher Hanoun, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 3, 2021
New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19
Sarah Esther Chang, Allan Feng, Wenzhao Meng, et al.
Leukemia
|
January 12, 2026
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)
Andreas Burchert, Franck E Nicolini, Philipp le Coutre, et al.
BMC Cancer
|
December 7, 2016
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011
Olaf Schoffer, Stefanie Schülein, Gerlinde Arand, et al.
Page
of 23